Clinical Trial Update: Evaluation of the Safety and Immune Response to an Investigational Dengue Type 1 Vaccine [Phase 1]

View source ↗

Summary

This document reports results from a Phase 1 trial evaluating the safety and immune response of an investigational Dengue virus type 1 vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue Fever

Drugs mentioned

• Dengue Type 1 vaccine (Dengue virus serotype 1 vaccine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Dengue Virus | Phase 1 | Status: COMPLETED